PD-1 checkpoint blockade in advanced melanoma patients: NK cells, monocytic subsets and host PD-L1 expression as predictive biomarker candidates

Blockade of the PD-1 receptor has revolutionized the treatment of metastatic melanoma, with significant increases in overall survival (OS) and a dramatic improvement in patient quality of life. Despite the success of this approach, the number of benefitting patients is limited and there is a need fo...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncoimmunology
Hlavní autoři: Pico de Coaña, Yago, Wolodarski, Maria, van der Haar Àvila, Irene, Nakajima, Takahiro, Rentouli, Stamatina, Lundqvist, Andreas, Masucci, Giuseppe, Hansson, Johan, Kiessling, Rolf
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2020
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7470181/
https://ncbi.nlm.nih.gov/pubmed/32939320
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1786888
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky